Clinical Trial Update: Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing ibandronate versus zoledronic acid in patients with newly diagnosed bone metastases from breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Drugs mentioned

• Ibandronate (ibandronate)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Wales Cancer Trials Unit | Conditions: Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Status: UNKNOWN